tiprankstipranks
Healthequity (DE:2HE)
XETRA:2HE
Germany Market
2HE
Healthequity
RESEARCH TOOLSreports

Healthequity (2HE) Ratios

3 Followers

Healthequity Ratios

DE:2HE's free cash flow for Q2 2027 was $0.74. For the 2027 fiscal year, DE:2HE's free cash flow was decreased by $ and operating cash flow was $0.29. See a summary of the company’s cash flow.
Ratios
TTM
Jan 26Jan 25Jan 24Jan 23
Liquidity Ratios
Current Ratio
 2.99 3.27 3.06 4.76 2.92
Quick Ratio
 2.99 3.27 3.06 4.76 2.92
Cash Ratio
 1.66 2.03 1.89 3.45 1.94
Solvency Ratio
 0.29 0.28 0.19 0.18 0.11
Operating Cash Flow Ratio
 3.19 2.91 2.17 2.07 1.15
Short-Term Operating Cash Flow Coverage
 49.16 0.00 0.00 0.00 8.61
Net Current Asset Value
$ -821.05M$ -812.57M$ -855.89M$ -571.33M$ -810.37M
Leverage Ratios
Debt-to-Assets Ratio
 0.30 0.29 0.32 0.29 0.32
Debt-to-Equity Ratio
 0.49 0.48 0.52 0.46 0.52
Debt-to-Capital Ratio
 0.33 0.32 0.34 0.31 0.34
Long-Term Debt-to-Capital Ratio
 0.32 0.31 0.33 0.30 0.32
Financial Leverage Ratio
 1.64 1.63 1.63 1.55 1.63
Debt Service Coverage Ratio
 6.36 7.47 5.25 4.74 2.78
Interest Coverage Ratio
 6.64 5.64 3.79 2.31 0.78
Debt to Market Cap
 0.12 0.13 0.11 0.14 0.18
Interest Debt Per Share
 12.28 12.29 13.46 11.55 12.35
Net Debt to EBITDA
 1.52 1.40 2.41 1.87 4.32
Profitability Margins
Gross Profit Margin
75.21%69.52%57.73%53.01%45.90%
EBIT Margin
24.77%25.47%14.59%12.94%1.20%
EBITDA Margin
34.47%37.25%28.13%28.25%19.90%
Operating Profit Margin
25.61%24.55%19.18%12.82%4.37%
Pretax Profit Margin
22.66%21.12%9.67%7.51%-4.42%
Net Profit Margin
17.36%16.38%8.06%5.57%-3.03%
Continuous Operations Profit Margin
17.36%16.38%8.06%5.57%-3.03%
Net Income Per EBT
76.61%77.57%83.34%74.24%68.62%
EBT Per EBIT
88.49%86.04%50.43%58.56%-101.18%
Return on Assets (ROA)
7.23%6.27%2.80%1.76%-0.85%
Return on Equity (ROE)
11.43%10.21%4.57%2.74%-1.38%
Return on Capital Employed (ROCE)
11.19%9.85%6.99%4.21%1.27%
Return on Invested Capital (ROIC)
8.55%7.61%5.81%3.11%0.87%
Return on Tangible Assets
41.10%31.34%16.23%8.20%-5.18%
Earnings Yield
3.00%2.92%1.01%0.86%-0.51%
Efficiency Ratios
Receivables Turnover
 11.15 10.62 10.17 9.53 8.90
Payables Turnover
 39.30 32.92 35.32 39.01 33.55
Inventory Turnover
 0.00 0.00 0.00 0.00 0.00
Fixed Asset Turnover
 36.13 33.26 25.84 18.38 12.43
Asset Turnover
 0.42 0.38 0.35 0.32 0.28
Working Capital Turnover Ratio
 4.28 3.88 3.15 2.89 3.83
Cash Conversion Cycle
 23.46 23.29 25.57 28.95 30.13
Days of Sales Outstanding
 32.74 34.37 35.90 38.30 41.02
Days of Inventory Outstanding
 0.00 0.00 0.00 0.00 0.00
Days of Payables Outstanding
 9.29 11.09 10.33 9.36 10.88
Operating Cycle
 32.74 34.37 35.90 38.30 41.02
Cash Flow Ratios
Operating Cash Flow Per Share
 5.88 5.31 3.91 2.84 1.78
Free Cash Flow Per Share
 5.66 5.28 3.89 2.30 0.37
CapEx Per Share
 0.22 0.02 0.02 0.54 1.41
Free Cash Flow to Operating Cash Flow
 0.96 1.00 0.99 0.81 0.21
Dividend Paid and CapEx Coverage Ratio
 26.49 232.15 163.08 5.27 1.26
Capital Expenditure Coverage Ratio
 26.49 232.15 163.08 5.27 1.26
Operating Cash Flow Coverage Ratio
 0.50 0.46 0.31 0.26 0.15
Operating Cash Flow to Sales Ratio
 0.36 0.35 0.28 0.24 0.17
Free Cash Flow Yield
5.97%6.17%3.52%3.04%0.61%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
 33.77 34.27 99.48 116.08 -196.55
Price-to-Sales (P/S) Ratio
 5.80 5.62 7.99 6.47 5.96
Price-to-Book (P/B) Ratio
 3.96 3.50 4.54 3.18 2.71
Price-to-Free Cash Flow (P/FCF) Ratio
 16.76 16.21 28.40 32.87 163.00
Price-to-Operating Cash Flow Ratio
 16.08 16.14 28.22 26.63 34.11
Price-to-Earnings Growth (PEG) Ratio
 0.51 0.27 1.41 -0.37 4.73
Price-to-Fair Value
 3.96 3.50 4.54 3.18 2.71
Enterprise Value Multiple
 18.36 16.48 30.82 24.77 34.27
Enterprise Value
 8.62B 8.06B 10.40B 7.00B 5.88B
EV to EBITDA
 18.36 16.48 30.82 24.77 34.27
EV to Sales
 6.33 6.14 8.67 7.00 6.82
EV to Free Cash Flow
 18.27 17.71 30.80 35.56 186.48
EV to Operating Cash Flow
 17.58 17.64 30.62 28.81 39.02
Tangible Book Value Per Share
 -8.47 -7.41 -8.49 -5.25 -8.16
Shareholders’ Equity Per Share
 23.87 24.46 24.35 23.78 22.45
Tax and Other Ratios
Effective Tax Rate
 0.23 0.22 0.17 0.26 0.31
Revenue Per Share
 16.34 15.25 13.81 11.68 10.21
Net Income Per Share
 2.84 2.50 1.11 0.65 -0.31
Tax Burden
 0.77 0.78 0.83 0.74 0.69
Interest Burden
 0.91 0.83 0.66 0.58 -3.69
Research & Development to Revenue
 0.20 0.20 0.20 0.22 0.22
SG&A to Revenue
 0.25 0.25 0.19 0.10 0.11
Stock-Based Compensation to Revenue
 0.06 0.06 0.08 0.08 0.07
Income Quality
 2.07 2.12 3.51 4.36 -5.76
Currency in USD